Monday, June 1, 2020

Gilead's Remdesivir Shows Fair Improvement In Moderate COVID-19 Patients

Gilead Sciences Inc on Monday reported that its antiviral drug remdesivir provided a modest benefit in patients with moderate COVID-19 given a five-day course of the treatment, while those who...

from NDTV News - World-news https://ift.tt/36PjXS6
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

On Run Since 2025, Criminal Posing As 'Peer Baba' Arrested By Hyderabad Cops

During the operation, police seized 115 grams of dry ganja (Cannabis) and the Peer Baba attire allegedly used by the accused to avoid detect...